GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (LTS:0UGB) » Definitions » Short Percentage of Float

Cosciens Biopharma (LTS:0UGB) Short Percentage of Float


View and export this data going back to 2024. Start your Free Trial

What is Cosciens Biopharma Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Cosciens Biopharma's Short Percentage of Float

For the Biotechnology subindustry, Cosciens Biopharma's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosciens Biopharma's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cosciens Biopharma's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Cosciens Biopharma's Short Percentage of Float falls into.


;
;

Cosciens Biopharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (LTS:0UGB) » Definitions » Short Percentage of Float
Comparable Companies
XCNQ:TELI TSXV:KNE XCNQ:PREV TSXV:HEM XCNQ:BETR XCNQ:MDMA TSXV:SBM XCNQ:BIOV TSX:RVX TSXV:CYTO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
CSCI:USA ET8:Germany CSCI:Canada
Address
c/o Norton Rose Fulbright Canada LLP, 222 Bay Street, Suite 3000, P.O. Box 53, Toronto, ON, CAN, M5K 1E7
Website
https://www.zentaris.com
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.

Cosciens Biopharma Headlines

No Headlines